The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I/II study of dianhydrogalactitol in patients with recurrent malignant glioblastoma multiforme (GBM).
Kent C. Shih
No relevant relationships to disclose
Manish R. Patel
No relevant relationships to disclose
Nicholas A. Butowski
Research Funding - Del Mar Pharmaceuticals
Jeffrey A. Bacha
Employment or Leadership Position - Del Mar Pharmaceuticals
Stock Ownership - Del Mar Pharmaceuticals
Dennis Brown
Employment or Leadership Position - Del Mar Pharmaceuticals
Consultant or Advisory Role - Del Mar Pharmaceuticals
Stock Ownership - Del Mar Pharmaceuticals (B)
William J. Garner
Employment or Leadership Position - Del Mar Pharmaceuticals
Consultant or Advisory Role - Del Mar Pharmaceuticals
Stock Ownership - Del Mar Pharmaceuticals (B)
Anne Steino
Employment or Leadership Position - Del Mar Pharmaceuticals
Consultant or Advisory Role - Del Mar Pharmaceuticals
Stock Ownership - Del Mar Pharmaceuticals
Richard Stephen Schwartz
Consultant or Advisory Role - Del Mar Pharmaceuticals
Stock Ownership - Del Mar Pharmaceuticals
Sarath Kanekal
Consultant or Advisory Role - Del Mar Pharmaceuticals
Stock Ownership - Del Mar Pharmaceuticals
Lorena Lopez
Consultant or Advisory Role - Del Mar Pharmaceuticals
Howard A. Burris
No relevant relationships to disclose